Support the "Master" Antioxidant
CJC-1295 is a synthetic analog of GHRH that has been modified to significantly extend its biological half-life
This was the case in our pre-registered primary analysis (where we report a significant group effect across groups of participants with type-2 diabetes, on and off semaglutide, and BMI-matched and -unmatched healthy controls, which numerically show decreasing acceptance bias), and in our exploratory dimensional finding that increasing risk of diabetes is associated with lower acceptance bias across study groups
In some cases, patients had side effects that required medical attention or had to go to the hospital
The latter is not FDA-approved and typically requires out-of-pocket payment
These mediators extend beyond adipose depots, propagating systemic inflammation, endothelial dysfunction, and oxidative stress